Company Overview and News

 
Unichem Laboratories Limited - Retirement

2018-09-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
D-Street Buzz: Pharma, FMCG stocks gain led by Cadila Health ITC; Infosys hits new record high

2018-08-17 moneycontrol
The Indian benchmark indices this Friday morning are trading on a bullish note with the Nifty jumping 66 points at 11, 451 while the Sensex rallied 244 points and is trading at 37,907.
HINDCOPPER AUROPHARMA 500228 UBL HNDZY 511389 VIDEOIND 532478 CADILAHC 535789 532321 500470 533207 506690 UNICHEMLAB HINDALCO 524804 IDKQY UBHOLDINGS 513599 CANFINHOME 511196 UNBWY JSWSTEEL CDLYY VTL IBULHSGFIN HNDNF TTST BATAINDIA TATASTEEL JPINFRATEC TATLY ARBQY 502986 507458 500043 500440 500188 HINDZINC

 
Unichem Laboratories Limited - ESOP/ESOS/ESPS

2018-08-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
USFDA makes four observations to Unichem Labs for Roha facility

2018-08-06 moneycontrol
Drug firm Unichem Laboratories today said the US health regulator has made four observations after inspection of its active pharmaceutical ingredient (API) manufacturing facility at Roha in Maharashtra.
UNICHEMLAB 506690

 
Torrent Pharma hits 52-week high post Q1 nos; brokerages raise target price

2018-08-03 moneycontrol
Shares of Torrent Pharmaceuticals has touched 52-week high of Rs 1,651.50, rising 8.5 percent intraday Friday despite company's net profit declined in the quarter ended June 2018.
UNICHEMLAB TORNTPHARM TQRRY 506690 500420

 
Torrent Pharma Q1 profit dips 13% at ₹163 crore

2018-08-02 livemint
New Delhi: Torrent Pharmaceuticals on Thursday reported 13.29% decline in its consolidated net profit at ₹163 crore for the first quarter ended 30 June. The company had posted a net profit of ₹188 crore during the same period of the previous fiscal.
UNICHEMLAB TORNTPHARM TQRRY 506690 500420

 
Unichem Laboratories slips 3% on USFDA observations for Pithampur unit

2018-08-01 moneycontrol
Shares of Unichem Laboratories slipped 3.5 percent intraday Wednesday as company received 4 USFDA observations for Pithampur unit.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Press Release

2018-08-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Shareholders meeting

2018-07-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Shareholders meeting

2018-07-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Shareholders meeting

2018-07-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Financial Result Updates

2018-07-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Outcome of Board Meeting

2018-07-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

 
Unichem Laboratories Limited - Shareholders meeting

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UNICHEMLAB 506690

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...